Majority (80%) of VHL patients develop central nervous system hemangioblastomas (HBs), with tumor development driven by VHL protein (pVHL) loss, resulting in hypoxia inducible factor (HIF) 1α and HIF-2α accumulation1, 2, 3. The gene discussed is EPAS1; the disease is neoplasm.